beas 2b cell (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
beas 2b cell
Beas 2b Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3986 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beas+2b/BEAS-2B/pm42320433-336-0-7
Average 99 stars, based on 3986 article reviews
Beas 2b Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3986 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beas+2b/BEAS-2B/pm42320433-336-0-7
Average 99 stars, based on 3986 article reviews
beas 2b cell - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Mutagenesis:Article Title: Single-cell and spatial transcriptomic profiling of POU5F1 in Lung Adenocarcinoma: Dynamics, spatial niche, and prognosis via multi-algorithm ML. Article Snippet: .. The following cell lines from the American Type Culture Collection (ATCC) were used: Cell Culture:Article Title: Dioscin alleviates allergic airway inflammation with IL-4R-associated modulation of epithelial-immune responses. Article Snippet: Objective: Allergic asthma is characterized by airway inflammation, epithelial barrier dysfunction, and dysregulated immune responses.. While Th2 cytokines and IL-4 receptor (IL-4R) signaling are central to its pathogenesis, accumulating evidence underscores the involvement of epithelial–immune interactions, metabolic disturbances, and gut–lung axis dysregulation.. Dioscin, a natural steroidal saponin, has demonstrated antiinflammatory properties, but its role in airway inflammation remains insufficiently explored. Article Title: Network-based single-cell analysis identifies a proliferative GZMB + plasma cell subset linked to Hedgehog signaling and prognostic risk in lung squamous cell carcinoma. Article Snippet: .. 166 AR TIC LE IN PR ES S 2.5 Supplementary experimental methods 167 2.5.1 Cell culture 168 The Article Title: Repurposing drugs for EGFR-targeted cancer therapy: An in silico and in vitro study with pharmacophore-based insights. Article Snippet: Cancer is the second leading cause of death globally and remains a priority due to its impact on life quality, treatment complexity, and high costs.. To expedite drug development, researchers are increasingly repurposing FDA-approved drugs and clinical candidates, reducing time and costs through in silico methods.. In this study, 3235 FDA-approved and clinical molecules were screened for EGFR inhibition, a significant target due to its role in cancer progression and treatment resistance. Modification:Article Title: Repurposing drugs for EGFR-targeted cancer therapy: An in silico and in vitro study with pharmacophore-based insights. Article Snippet: Cancer is the second leading cause of death globally and remains a priority due to its impact on life quality, treatment complexity, and high costs.. To expedite drug development, researchers are increasingly repurposing FDA-approved drugs and clinical candidates, reducing time and costs through in silico methods.. In this study, 3235 FDA-approved and clinical molecules were screened for EGFR inhibition, a significant target due to its role in cancer progression and treatment resistance. |
